Sublingual and oral immunotherapy

作者: Giorgio Walter Canonica , Enrico Compalati , Federica Fumagalli , Giovanni Passalacqua

DOI: 10.1016/J.IAC.2004.07.001

关键词: SlitSafety profileOral administrationSubcutaneous routeSublingual immunotherapyDermatologyMedicineImmunotherapyAsthmaOral immunotherapySurgery

摘要: Sublingual immunotherapy (SLIT) is a viable alternative to the subcutaneous route for treatment of respiratory allergy, whereas pure oral has been abandoned because its lack efficacy. The main distinctive feature SLIT optimal safety profile, which demonstrated in adults and children. indications are similar those route. A long-lasting effect sublingual route, but data needed determine dose preventive asthma.

参考文章(119)
P Bernardis, M Pozzan, M Agnoletto, S Parmiani, P Puccinelli, Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. Journal of Investigational Allergology and Clinical Immunology. ,vol. 6, pp. 55- 62 ,(1996)
Lattuada G, Dall'Aglio Pp, Feliziani, Parmiani S, Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergologia Et Immunopathologia. ,vol. 23, pp. 224- 230 ,(1995)
Horak F, Marks B, Stübner P, Berger Ue, Toth J, Jäger S, Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. Journal of Investigational Allergology and Clinical Immunology. ,vol. 8, pp. 165- 171 ,(1998)
G Monti, M G Tari, M Mancino, Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergologia Et Immunopathologia. ,vol. 18, pp. 277- 284 ,(1990)
Janosky J, Henry J, Friday Ga, Mandik L, Lower T, Compliance with allergen immunotherapy. Annals of allergy. ,vol. 70, pp. 480- 482 ,(1993)
Elena Battistini, Federica Sabatini, Giovanni A. Rossi, Michela Silvestri, Daniela Spallarossa, Silvia Pecora, Silvano Parmiani, Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy. Journal of Investigational Allergology and Clinical Immunology. ,vol. 12, pp. 52- 59 ,(2002)
A DESROCHES, L PARADIS, J MENARDO, S BOUGES, J DAURES, J BOUSQUET, Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. The Journal of Allergy and Clinical Immunology. ,vol. 99, pp. 450- 453 ,(1997) , 10.1016/S0091-6749(97)70069-1
V. Di Rienzo, A. Pagani, S. Parmiani, G. Passalacqua, G.W. Canonica, Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy. ,vol. 54, pp. 1110- 1113 ,(1999) , 10.1034/J.1398-9995.1999.00267.X
H. Mosbech, S. Dreborg, F. Madsen, H. Ohlsson, P. Stahl Skov, E. Taudorf, B. Weeke, High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study. Allergy. ,vol. 42, pp. 451- 455 ,(1987) , 10.1111/J.1398-9995.1987.TB00362.X
Philippe Eigenmann, G Senti, B Wüthrich, A Bircher, P Eng, Y Schneider, Ch Bucher, F Schnyder, W Jörg, Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. Journal of Investigational Allergology and Clinical Immunology. ,vol. 13, pp. 145- ,(2003)